Mycobacterium Riyadhense Clinical Cases: A Systematic Review of 69 Cases from 2009-2025

A 2026 systematic review by Hassan Almarhabi synthesizes 22 studies published between 2009 and 2025, reporting on 69 cases of Mycobacterium riyadhense infection. The dataset includes patient demographics, clinical presentations, and antimicrobial susceptibility results. It was compiled from PubMed, Web of Science, and Google Scholar following PRISMA guidelines.

Use Cases

• Analyzing demographic and clinical presentation patterns based on the reported median age, gender distribution, and infection types.
• Studying antimicrobial susceptibility profiles based on the reported resistance to Isoniazid and susceptibility to Rifampin and Ethambutol.
• Identifying gaps in diagnostic and treatment standardization based on the review's conclusion about significant variability.
• Conducting meta-analyses on emerging mycobacterial infections based on the aggregated case data from multiple studies.

Strengths

• Includes data on 69 individual clinical cases, providing a consolidated view of this emerging pathogen.
• Reports specific findings such as a patient median age of 35.5 and that 80% of cases were male.
• Contains antimicrobial susceptibility results, noting resistance in 5 out of 8 tested isolates for Isoniazid.
• Follows a systematic methodology (PRISMA) with a pre-registered protocol (CRD420250653025).

Limitations

• Row count and column-level documentation are absent; field semantics must be inferred after download.
• The dataset is small at 75.5 KB, representing a limited scope of aggregated literature findings.
• Data may reflect publication bias inherent to the systematic review's source databases and inclusion criteria.

Provenance

Source

Hassan Almarhabi via figshare.

Collection Method

Systematic literature review of PubMed, Web of Science, and Google Scholar.

Time Range

Publications from 2009 to 2025.

Freshness

Last updated 2026-04-13 05:20:47.

Geography

null